A citation-based method for searching scientific literature

Maria Elisa Mancuso, Johnny N Mahlangu, Steven W Pipe. Lancet 2021
Times Cited: 21







List of co-cited articles
146 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


WFH Guidelines for the Management of Hemophilia, 3rd edition.
Alok Srivastava, Elena Santagostino, Alison Dougall, Steve Kitchen, Megan Sutherland, Steven W Pipe, Manuel Carcao, Johnny Mahlangu, Margaret V Ragni, Jerzy Windyga,[...]. Haemophilia 2020
282
47

Emicizumab Prophylaxis in Patients Who Have Hemophilia A without Inhibitors.
Johnny Mahlangu, Johannes Oldenburg, Ido Paz-Priel, Claude Negrier, Markus Niggli, M Elisa Mancuso, Christophe Schmitt, Victor Jiménez-Yuste, Christine Kempton, Christophe Dhalluin,[...]. N Engl J Med 2018
282
33

Emicizumab Prophylaxis in Hemophilia A with Inhibitors.
Johannes Oldenburg, Johnny N Mahlangu, Benjamin Kim, Christophe Schmitt, Michael U Callaghan, Guy Young, Elena Santagostino, Rebecca Kruse-Jarres, Claude Negrier, Craig Kessler,[...]. N Engl J Med 2017
466
33

Definitions in hemophilia: communication from the SSC of the ISTH.
V S Blanchette, N S Key, L R Ljung, M J Manco-Johnson, H M van den Berg, A Srivastava. J Thromb Haemost 2014
332
28

2021 clinical trials update: Innovations in hemophilia therapy.
Stacy E Croteau, Michael Wang, Allison P Wheeler. Am J Hematol 2021
17
29

A multicentre, open-label study of emicizumab given every 2 or 4 weeks in children with severe haemophilia A without inhibitors.
Midori Shima, Keiji Nogami, Sayaka Nagami, Seitaro Yoshida, Koichiro Yoneyama, Akira Ishiguro, Takashi Suzuki, Masashi Taki. Haemophilia 2019
55
23

BIVV001 Fusion Protein as Factor VIII Replacement Therapy for Hemophilia A.
Barbara A Konkle, Amy D Shapiro, Doris V Quon, Janice M Staber, Roshni Kulkarni, Margaret V Ragni, Ekta S Chhabra, Stacey Poloskey, Kara Rice, Suresh Katragadda,[...]. N Engl J Med 2020
21
23

Hemophilia therapy: the future has begun.
Pier Mannuccio Mannucci. Haematologica 2020
57
23

Multiyear Follow-up of AAV5-hFVIII-SQ Gene Therapy for Hemophilia A.
K John Pasi, Savita Rangarajan, Nina Mitchell, Will Lester, Emily Symington, Bella Madan, Michael Laffan, Chris B Russell, Mingjin Li, Glenn F Pierce,[...]. N Engl J Med 2020
149
23

A Molecular Revolution in the Treatment of Hemophilia.
John S S Butterfield, Kerry M Hege, Roland W Herzog, Radoslaw Kaczmarek. Mol Ther 2020
35
19

Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries.
Alfonso Iorio, Jeffrey S Stonebraker, Hervé Chambost, Michael Makris, Donna Coffin, Christine Herr, Federico Germini. Ann Intern Med 2019
99
19

Current Clinical Applications of In Vivo Gene Therapy with AAVs.
Jerry R Mendell, Samiah A Al-Zaidy, Louise R Rodino-Klapac, Kimberly Goodspeed, Steven J Gray, Christine N Kay, Sanford L Boye, Shannon E Boye, Lindsey A George, Stephanie Salabarria,[...]. Mol Ther 2021
78
19

Phase 3 study of recombinant factor VIII Fc fusion protein in severe hemophilia A.
Johnny Mahlangu, Jerry S Powell, Margaret V Ragni, Pratima Chowdary, Neil C Josephson, Ingrid Pabinger, Hideji Hanabusa, Naresh Gupta, Roshni Kulkarni, Patrick Fogarty,[...]. Blood 2014
308
19

AAV5-Factor VIII Gene Transfer in Severe Hemophilia A.
Savita Rangarajan, Liron Walsh, Will Lester, David Perry, Bella Madan, Michael Laffan, Hua Yu, Christian Vettermann, Glenn F Pierce, Wing Y Wong,[...]. N Engl J Med 2017
348
19

Efficacy, safety, and pharmacokinetics of emicizumab prophylaxis given every 4 weeks in people with haemophilia A (HAVEN 4): a multicentre, open-label, non-randomised phase 3 study.
Steven W Pipe, Midori Shima, Michaela Lehle, Amy Shapiro, Sammy Chebon, Katsuyuki Fukutake, Nigel S Key, Agnès Portron, Christophe Schmitt, Maria Podolak-Dawidziak,[...]. Lancet Haematol 2019
131
19

A multicenter, open-label phase 3 study of emicizumab prophylaxis in children with hemophilia A with inhibitors.
Guy Young, Ri Liesner, Tiffany Chang, Robert Sidonio, Johannes Oldenburg, Victor Jiménez-Yuste, Johnny Mahlangu, Rebecca Kruse-Jarres, Michael Wang, Marianne Uguen,[...]. Blood 2019
114
19


Update on clinical gene therapy for hemophilia.
George Q Perrin, Roland W Herzog, David M Markusic. Blood 2019
74
19

The past and future of haemophilia: diagnosis, treatments, and its complications.
Flora Peyvandi, Isabella Garagiola, Guy Young. Lancet 2016
197
19

Long-term safety and efficacy of factor IX gene therapy in hemophilia B.
Amit C Nathwani, Ulreke M Reiss, Edward G D Tuddenham, Cecilia Rosales, Pratima Chowdary, Jenny McIntosh, Marco Della Peruta, Elsa Lheriteau, Nishal Patel, Deepak Raj,[...]. N Engl J Med 2014
744
19

Hemophilia B Gene Therapy with a High-Specific-Activity Factor IX Variant.
Lindsey A George, Spencer K Sullivan, Adam Giermasz, John E J Rasko, Benjamin J Samelson-Jones, Jonathan Ducore, Adam Cuker, Lisa M Sullivan, Suvankar Majumdar, Jerome Teitel,[...]. N Engl J Med 2017
359
19

Inhibitors in haemophilia A and B: Management of bleeds, inhibitor eradication and strategies for difficult-to-treat patients.
Rolf Ljung, Guenter Auerswald, Gary Benson, Gerry Dolan, Anne Duffy, Cedric Hermans, Victor Jiménez-Yuste, Thierry Lambert, Massimo Morfini, Silva Zupančić-Šalek,[...]. Eur J Haematol 2019
32
14

Past, present and future of hemophilia: a narrative review.
Massimo Franchini, Pier Mannuccio Mannucci. Orphanet J Rare Dis 2012
128
14

Paradigm shift for the treatment of hereditary haemophilia: Towards precision medicine.
Gaia Spadarella, Alessandro Di Minno, Graziella Milan, Nicoletta Franco, Mariateresa Polimeno, Francesco Castaldo, Giovanni Di Minno. Blood Rev 2020
16
18

Burden on parents of children with haemophilia: The impact of sociodemographic and child's medical condition.
Linda Myrin Westesson, Carina Sparud-Lundin, Fariba Baghaei, Kate Khair, Sylvia von Mackensen, Mariela Acuña Mora, Catarina Wallengren. J Clin Nurs 2019
7
42

Long-term outcomes with emicizumab prophylaxis for hemophilia A with or without FVIII inhibitors from the HAVEN 1-4 studies.
Michael U Callaghan, Claude Negrier, Ido Paz-Priel, Tiffany Chang, Sammy Chebon, Michaela Lehle, Johnny Mahlangu, Guy Young, Rebecca Kruse-Jarres, Maria Elisa Mancuso,[...]. Blood 2021
22
14

Targeting of Antithrombin in Hemophilia A or B with RNAi Therapy.
K John Pasi, Savita Rangarajan, Pencho Georgiev, Tim Mant, Michael D Creagh, Toshko Lissitchkov, David Bevan, Steve Austin, Charles R Hay, Inga Hegemann,[...]. N Engl J Med 2017
191
14

Practical Guidance of the GTH Haemophilia Board on the Use of Emicizumab in Patients with Haemophilia A.
Katharina Holstein, Manuela Albisetti, Christoph Bidlingmaier, Susan Halimeh, Sabine Heine, Robert Klamroth, Christoph Königs, Karin Kurnik, Christoph Male, Johannes Oldenburg,[...]. Hamostaseologie 2020
8
37

Pegylated, full-length, recombinant factor VIII for prophylactic and on-demand treatment of severe hemophilia A.
Barbara A Konkle, Oleksandra Stasyshyn, Pratima Chowdary, David H Bevan, Tim Mant, Midori Shima, Werner Engl, Jacqueline Dyck-Jones, Monika Fuerlinger, Lisa Patrone,[...]. Blood 2015
156
14

Real-world use of emicizumab in patients with haemophilia A: Bleeding outcomes and surgical procedures.
Isabella McCary, Christine Guelcher, Jan Kuhn, Regina Butler, Gita Massey, Michael F Guerrera, Lance Ballester, Leslie Raffini. Haemophilia 2020
23
14


Treatment and Prevention of Bleeds in Haemophilia Patients with Inhibitors to Factor VIII/IX.
Angiola Rocino, Massimo Franchini, Antonio Coppola. J Clin Med 2017
35
14

Life in the shadow of a dominant partner: the FVIII-VWF association and its clinical implications for hemophilia A.
Steven W Pipe, Robert R Montgomery, Kathleen P Pratt, Peter J Lenting, David Lillicrap. Blood 2016
93
14

Haemophilias A and B.
Paula H B Bolton-Maggs, K John Pasi. Lancet 2003
472
14

The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
Alice Trinchero, Michelle Sholzberg, Davide Matino. Hamostaseologie 2020
8
37

Impact of haemophilia on patients with mild-to-moderate disease: Results from the P-FiQ and B-HERO-S studies.
Michelle Witkop, Michael Wang, Grace Hernandez, Michael Recht, Kim Baumann, David L Cooper. Haemophilia 2021
5
60

Young adult outcomes of childhood prophylaxis for severe hemophilia A: results of the Joint Outcome Continuation Study.
Beth Boulden Warren, Dianne Thornhill, Jill Stein, Michael Fadell, J David Ingram, Sharon Funk, Kristi L Norton, Heidi D Lane, Carolyn M Bennett, Amy Dunn,[...]. Blood Adv 2020
28
14

Prophylaxis versus episodic treatment to prevent joint disease in boys with severe hemophilia.
Marilyn J Manco-Johnson, Thomas C Abshire, Amy D Shapiro, Brenda Riske, Michele R Hacker, Ray Kilcoyne, J David Ingram, Michael L Manco-Johnson, Sharon Funk, Linda Jacobson,[...]. N Engl J Med 2007
14

Target-Cell-Directed Bioengineering Approaches for Gene Therapy of Hemophilia A.
Harrison C Brown, Philip M Zakas, Stephan N George, Ernest T Parker, H Trent Spencer, Christopher B Doering. Mol Ther Methods Clin Dev 2018
22
14

Adenovirus-associated virus vector-mediated gene transfer in hemophilia B.
Amit C Nathwani, Edward G D Tuddenham, Savita Rangarajan, Cecilia Rosales, Jenny McIntosh, David C Linch, Pratima Chowdary, Anne Riddell, Arnulfo Jaquilmac Pie, Chris Harrington,[...]. N Engl J Med 2011
14

BAX 335 hemophilia B gene therapy clinical trial results: potential impact of CpG sequences on gene expression.
Barbara A Konkle, Christopher E Walsh, Miguel A Escobar, Neil C Josephson, Guy Young, Annette von Drygalski, Scott W J McPhee, R Jude Samulski, Ivan Bilic, Maurus de la Rosa,[...]. Blood 2021
27
14

Therapeutic levels of FVIII following a single peripheral vein administration of rAAV vector encoding a novel human factor VIII variant.
Jenny McIntosh, Peter J Lenting, Cecilia Rosales, Doyoung Lee, Samira Rabbanian, Deepak Raj, Nishil Patel, Edward G D Tuddenham, Olivier D Christophe, John H McVey,[...]. Blood 2013
177
14

Tolerating Factor VIII: Recent Progress.
Sebastien Lacroix-Desmazes, Jan Voorberg, David Lillicrap, David W Scott, Kathleen P Pratt. Front Immunol 2020
22
9

Oral Tolerance Induction in Hemophilia B Dogs Fed with Transplastomic Lettuce.
Roland W Herzog, Timothy C Nichols, Jin Su, Bei Zhang, Alexandra Sherman, Elizabeth P Merricks, Robin Raymer, George Q Perrin, Mattias Häger, Bo Wiinberg,[...]. Mol Ther 2017
39
9

Inhibitors in Hemophilia B.
Cristina Santoro, Gabriele Quintavalle, Giancarlo Castaman, Erminia Baldacci, Antonietta Ferretti, Federica Riccardi, Annarita Tagliaferri. Semin Thromb Hemost 2018
18
11


Spectrum of F8 gene mutations in haemophilia A patients from a region of Italy: identification of 23 new mutations.
F Riccardi, A Tagliaferri, D Martorana, G F Rivolta, L Valdrè, G Rodorigo, C Biasoli, M D'Incà, M L Serino, S Macchi,[...]. Haemophilia 2010
13
15

Novel approach to genetic analysis and results in 3000 hemophilia patients enrolled in the My Life, Our Future initiative.
Jill M Johnsen, Shelley N Fletcher, Haley Huston, Sarah Roberge, Beth K Martin, Martin Kircher, Neil C Josephson, Jay Shendure, Sarah Ruuska, Marion A Koerper,[...]. Blood Adv 2017
46
9

A microRNA-regulated and GP64-pseudotyped lentiviral vector mediates stable expression of FVIII in a murine model of Hemophilia A.
Hideto Matsui, Carol Hegadorn, Margareth Ozelo, Erin Burnett, Angie Tuttle, Andrea Labelle, Paul B McCray, Luigi Naldini, Brian Brown, Christine Hough,[...]. Mol Ther 2011
57
9

Marstacimab, a tissue factor pathway inhibitor neutralizing antibody, improves coagulation parameters of ex vivo dosed haemophilic blood and plasmas.
Sunita Patel-Hett, Erika J Martin, Bassem M Mohammed, Swapnil Rakhe, Pengling Sun, John C Barrett, Melinda E Nolte, Janice Kuhn, Debra D Pittman, John E Murphy,[...]. Haemophilia 2019
14
14


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.